Transaction #27151 · Form 4 · 0001940413-26-000001
ImageneBio, Inc. · Stock award · Employee Stock Option (right to buy)
ImageneBio, Inc. · Transacted December 30, 2025 · Filed January 2, 2026
What does this filing report?
An SEC Form 4 filing for ImageneBio, Inc. records a stock award involving Employee Stock Option (right to buy) on December 30, 2025. The reported quantity was 22,500. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ImageneBio, Inc.
- Company CIK
- 0001835579
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 22,500
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 22,500
- Ownership description
- Not reported
- SEC acceptance time
- Jan 2, 2026, 9:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Butler Erin ↗
Principal Accounting Officer
CIK 0001940413
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 22,500
- Conversion / exercise price
- 7.11
- Exercise date
- Not reported
- Expiration date
- December 30, 2035
Filing footnotes & remarks
- F1
- Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 15, 2026, March 1, 2027, March 1, 2028 and March 1, 2029, in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")) through each such date.
- F2
- This option vests over four years, with 25% of the shares subject to this option vesting on July 15, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2025 Plan) through each such date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.